Efficacy， biomarkers， and safety assessment of Lecanemab in treatment of Chinese patients with Alzheimer disease： A 12-month real-world study

HE Sha, LIU Li, JI Yihan, GAO Yan, LI Yang, LIANG Ruijing, ZHAO Shuya, LI Mingkang, MA Xiaowei

Journal of Apoplexy and Nervous Diseases ›› 2026, Vol. 43 ›› Issue (6) : 498-504.

PDF(1838 KB)
PDF(1838 KB)
Journal of Apoplexy and Nervous Diseases ›› 2026, Vol. 43 ›› Issue (6) : 498-504. DOI: 10.19845/j.cnki.zfysjjbzz.2026.0086
Cognitive Disorder Section

Efficacy， biomarkers， and safety assessment of Lecanemab in treatment of Chinese patients with Alzheimer disease： A 12-month real-world study

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 43(6): 498-504 https://doi.org/10.19845/j.cnki.zfysjjbzz.2026.0086

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1838 KB)

Accesses

Citation

Detail
Sections
Recommended
Medical Publishing Centre of The First Hospital of Jilin University
Contact
Official website: www.zfysjjbzz.com
Official e-mail: zf_bjb@126.com
Official WeChat Platform: zfysjjbzz
Telephone number:(00)86-431-88782862/2863
Bank account information
Name: Jilin Dayijingcheng Media Co., Ltd.
Tax ID: 91220104MAC5259Q8T
Bank of deposit: Changchun Xi’an Road Sub-branch of China Construction Bank
Bank account: 22050145010009111679
Copyright © Editorial Office of Journal of Apoplexy and Nervous Diseases

/

〈 〉